These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 20959962)

  • 1. Changes in the contents of enzymatic immature, mature, and non-enzymatic senescent cross-links of collagen after once-weekly treatment with human parathyroid hormone (1-34) for 18 months contribute to improvement of bone strength in ovariectomized monkeys.
    Saito M; Marumo K; Kida Y; Ushiku C; Kato S; Takao-Kawabata R; Kuroda T
    Osteoporos Int; 2011 Aug; 22(8):2373-83. PubMed ID: 20959962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of 18-month treatment with bazedoxifene on enzymatic immature and mature cross-links and non-enzymatic advanced glycation end products, mineralization, and trabecular microarchitecture of vertebra in ovariectomized monkeys.
    Saito M; Kida Y; Nishizawa T; Arakawa S; Okabe H; Seki A; Marumo K
    Bone; 2015 Dec; 81():573-580. PubMed ID: 26385255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of raloxifene and alendronate on non-enzymatic collagen cross-links and bone strength in ovariectomized rabbits in sequential treatments after daily human parathyroid hormone (1-34) administration.
    Kimura S; Saito M; Kida Y; Seki A; Isaka Y; Marumo K
    Osteoporos Int; 2017 Mar; 28(3):1109-1119. PubMed ID: 27796444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Raloxifene ameliorates detrimental enzymatic and nonenzymatic collagen cross-links and bone strength in rabbits with hyperhomocysteinemia.
    Saito M; Marumo K; Soshi S; Kida Y; Ushiku C; Shinohara A
    Osteoporos Int; 2010 Apr; 21(4):655-66. PubMed ID: 19484165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Once-Weekly Teriparatide Treatment Prevents Microdamage Accumulation in the Lumbar Vertebral Trabecular Bone of Ovariectomized Cynomolgus Monkeys.
    Yoshitake S; Mashiba T; Saito M; Fujihara R; Iwata K; Takao-Kawabata R; Yamamoto T
    Calcif Tissue Int; 2019 Apr; 104(4):402-410. PubMed ID: 30564860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Collagen maturity, glycation induced-pentosidine, and mineralization are increased following 3-year treatment with incadronate in dogs.
    Saito M; Mori S; Mashiba T; Komatsubara S; Marumo K
    Osteoporos Int; 2008 Sep; 19(9):1343-54. PubMed ID: 18373056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of a weekly injection of human parathyroid hormone (1-34) and withdrawal on bone mass, strength, and turnover in mature ovariectomized rats.
    Okimoto N; Tsurukami H; Okazaki Y; Nishida S; Sakai A; Ohnishi H; Hori M; Yasukawa K; Nakamura T
    Bone; 1998 May; 22(5):523-31. PubMed ID: 9600787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Weekly teriparatide treatment increases vertebral body strength by improving cortical shell architecture in ovariectomized cynomolgus monkeys.
    Fujihara R; Mashiba T; Yoshitake S; Komatsubara S; Iwata K; Takao-Kawabata R; Yamamoto T
    Bone; 2019 Apr; 121():80-88. PubMed ID: 30630124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Teriparatide [PTH(1-34)] strengthens the proximal femur of ovariectomized nonhuman primates despite increasing porosity.
    Sato M; Westmore M; Ma YL; Schmidt A; Zeng QQ; Glass EV; Vahle J; Brommage R; Jerome CP; Turner CH
    J Bone Miner Res; 2004 Apr; 19(4):623-9. PubMed ID: 15005850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of parathyroid hormone (teriparatide) on bone quality in osteoporosis].
    Saito M; Marumo K
    Clin Calcium; 2012 Mar; 22(3):343-55. PubMed ID: 22370301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abaloparatide, a novel PTH receptor agonist, increased bone mass and strength in ovariectomized cynomolgus monkeys by increasing bone formation without increasing bone resorption.
    Doyle N; Varela A; Haile S; Guldberg R; Kostenuik PJ; Ominsky MS; Smith SY; Hattersley G
    Osteoporos Int; 2018 Mar; 29(3):685-697. PubMed ID: 29260289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of treatment with parathyroid hormone 1-84 on quantity and biomechanical properties of thoracic vertebral trabecular bone in ovariectomized rhesus monkeys.
    Fox J; Newman MK; Turner CH; Guldberg RE; Varela A; Smith SY
    Calcif Tissue Int; 2008 Mar; 82(3):212-20. PubMed ID: 18297227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of hPTH (1-34) and Gosha-jinki-gan on the trabecular bone microarchitecture in ovariectomized rat tibia.
    Yao X; Chen H; Emura S; Otake N; Shoumura S
    Okajimas Folia Anat Jpn; 2007 Feb; 83(4):107-13. PubMed ID: 17380852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histological Effects of the Combined Administration of Eldecalcitol and a Parathyroid Hormone in the Metaphyseal Trabeculae of Ovariectomized Rats.
    Hasegawa T; Yamamoto T; Sakai S; Miyamoto Y; Hongo H; Qiu Z; Abe M; Takeda S; Oda K; de Freitas PHL; Li M; Endo K; Amizuka N
    J Histochem Cytochem; 2019 Mar; 67(3):169-184. PubMed ID: 30311820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of skeletally mature ovariectomized rhesus monkeys with PTH(1-84) for 16 months increases bone formation and density and improves trabecular architecture and biomechanical properties at the lumbar spine.
    Fox J; Miller MA; Newman MK; Turner CH; Recker RR; Smith SY
    J Bone Miner Res; 2007 Feb; 22(2):260-73. PubMed ID: 17087625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of parathyroid hormone (teriparatide) on bone mass and quality in osteoporosis].
    Marumo K; Saito M
    Nihon Rinsho; 2011 Jul; 69(7):1264-9. PubMed ID: 21774369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intermittently administered human parathyroid hormone(1-34) treatment increases intracortical bone turnover and porosity without reducing bone strength in the humerus of ovariectomized cynomolgus monkeys.
    Burr DB; Hirano T; Turner CH; Hotchkiss C; Brommage R; Hock JM
    J Bone Miner Res; 2001 Jan; 16(1):157-65. PubMed ID: 11149480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolonged treatments with antiresorptive agents and PTH have different effects on bone strength and the degree of mineralization in old estrogen-deficient osteoporotic rats.
    Cheng Z; Yao W; Zimmermann EA; Busse C; Ritchie RO; Lane NE
    J Bone Miner Res; 2009 Feb; 24(2):209-20. PubMed ID: 18847326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Changes in bone quality and strength with bone-forming agents].
    Miyakoshi N
    Clin Calcium; 2016 Jan; 26(1):117-24. PubMed ID: 26728538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alendronate retards the progression of lumbar intervertebral disc degeneration in ovariectomized rats.
    Luo Y; Zhang L; Wang WY; Hu QF; Song HP; Su YL; Zhang YZ
    Bone; 2013 Aug; 55(2):439-48. PubMed ID: 23500174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.